"Small Sanyang" must also be treated.
Most patients with hepatitis B "small three-yang" have this experience: some experts told him that "small three-yang" does not need treatment, while others told him that "small three-yang" should be treated, and the harm of "small three-yang" is greater, and it is easier to turn into cirrhosis and liver cancer. Therefore, patients are often confused. Who should they listen to?
To make clear whether hepatitis B "small three yang" needs treatment, we must first make clear whether the people with "small three yang" belong to healthy people. It should be said that people with "small three-yang" are not healthy people, so different treatment schemes should be adopted according to the infection type of patients, the inflammatory activity of liver, the changes of liver function and whether HBV DNA is negative or positive. The experts who think that there is no need for treatment are a helpless choice based on the fact that there is no drug that is very effective for "Small Sanyang" in the past, especially interferon is not effective for patients with "Small Sanyang". If "small three positive" and hepatitis B virus DNA is positive, liver function test fluctuates repeatedly, which is often called atypical hepatitis in clinic, mainly caused by hepatitis B virus mutation, so antiviral treatment must be carried out. However, due to the poor curative effect of interferon, and interferon itself will cause virus mutation, it can not be used for the treatment of patients with "small three positive". If it is "small three positive", and the hepatitis B virus DNA is negative, and the liver function is normal, many doctors think that treatment is not needed, but through liver puncture, it is found that 90% of patients have inflammatory activities in their livers and have a tendency to fibrosis, and even some patients have developed early cirrhosis, so these patients should consider anti-fibrosis treatment. Most patients over 40 years old with a course of 10 years have different degrees of liver fibrosis. Active and effective treatment is of great significance to prevent the occurrence and development of liver cirrhosis, improve the prognosis of patients and improve their quality of life.
The situation of patients with small sanyang is not simpler than that of patients with large sanyang; Comprehensive analysis should be carried out according to the specific situation. HBV-DAN and liver function should be examined in patients with hepatitis B, and if HBV-DAN(+) and liver function is abnormal, it means that the virus is highly contagious and should be treated comprehensively with anti-virus. If the two halves of hepatitis B are small three positive, HBV-DAN (PCR and dot method should be used to detect at the same time; It is best confirmed by liver biopsy)) is (-) and the liver function, B-ultrasound and AFP are normal for a long time, which means that the virus has been cleared and is not contagious, so isolation and treatment are no longer needed; Because there is no recognized and effective drug that can further treat hepatitis B on the basis of this kind of small three-yang; Taking a large number of therapeutic Chinese and western medicines blindly after turning negative will only increase the burden on the liver or even lead to adverse consequences. If the liver continues to be inflamed, the probability of cirrhosis is high; Lycium barbarum can't be drunk in wine